Profile
Full Name
Tarsus Pharmaceuticals, Inc.Ticker Symbol
TARSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 16, 2020Indexes
Not includedWebsite
http://www.tarsusrx.comEmployees
323Key Details
Price
$49.25(-0.28%)
Market cap
$1.89B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$182.95M(+948.62% YoY)
Annual EPS
-$3.07(+33.55% YoY)
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Tarsus Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 6, 25 Jefferies
BuyFeb 26, 25 HC Wainwright & Co.
BuyFeb 26, 25 Guggenheim
BuyFeb 26, 25 Barclays
OverweightFeb 24, 25 Guggenheim
BuyFeb 10, 25 Guggenheim
BuyJan 27, 25 Barclays
OverweightJan 22, 25 Oppenheimer
OutperformNov 15, 24 Goldman Sachs
NeutralNov 14, 24 Oppenheimer
OutperformInstitutional Ownership
- What is the ticker symbol for Tarsus Pharmaceuticals?
- Does Tarsus Pharmaceuticals pay dividends?
- What sector is Tarsus Pharmaceuticals in?
- What industry is Tarsus Pharmaceuticals in?
- What country is Tarsus Pharmaceuticals based in?
- When did Tarsus Pharmaceuticals go public?
- Is Tarsus Pharmaceuticals in the S&P 500?
- Is Tarsus Pharmaceuticals in the NASDAQ 100?
- Is Tarsus Pharmaceuticals in the Dow Jones?
- When was Tarsus Pharmaceuticals's last earnings report?
- When does Tarsus Pharmaceuticals report earnings?
- Should I buy Tarsus Pharmaceuticals stock now?
What is the ticker symbol for Tarsus Pharmaceuticals?
The ticker symbol for Tarsus Pharmaceuticals is NASDAQ:TARS
Does Tarsus Pharmaceuticals pay dividends?
No, Tarsus Pharmaceuticals does not pay dividends
What sector is Tarsus Pharmaceuticals in?
Tarsus Pharmaceuticals is in the Healthcare sector
What industry is Tarsus Pharmaceuticals in?
Tarsus Pharmaceuticals is in the Biotechnology industry
What country is Tarsus Pharmaceuticals based in?
Tarsus Pharmaceuticals is headquartered in United States
When did Tarsus Pharmaceuticals go public?
Tarsus Pharmaceuticals's initial public offering (IPO) was on October 16, 2020
Is Tarsus Pharmaceuticals in the S&P 500?
No, Tarsus Pharmaceuticals is not included in the S&P 500 index
Is Tarsus Pharmaceuticals in the NASDAQ 100?
No, Tarsus Pharmaceuticals is not included in the NASDAQ 100 index
Is Tarsus Pharmaceuticals in the Dow Jones?
No, Tarsus Pharmaceuticals is not included in the Dow Jones index
When was Tarsus Pharmaceuticals's last earnings report?
Tarsus Pharmaceuticals's most recent earnings report was on Feb 25, 2025
When does Tarsus Pharmaceuticals report earnings?
The next expected earnings date for Tarsus Pharmaceuticals is May 8, 2025
Should I buy Tarsus Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions